189 related articles for article (PubMed ID: 24163335)
41. Panosialins, inhibitors of enoyl-ACP reductase from Streptomyces sp. AN1761.
Kwon YJ; Sohn MJ; Oh T; Cho SN; Kim CJ; Kim WG
J Microbiol Biotechnol; 2013 Feb; 23(2):184-8. PubMed ID: 23412060
[TBL] [Abstract][Full Text] [Related]
42. Biophysical library screening using a Thermo-FMN assay to identify and characterize Clostridioides difficile FabK inhibitors.
Pavel FBA; Palmer GE; Hevener KE
Biochem Biophys Res Commun; 2024 Apr; 705():149740. PubMed ID: 38458032
[TBL] [Abstract][Full Text] [Related]
43. Crystallization and preliminary X-ray crystallographic studies of enoyl-acyl carrier protein reductase (FabI) from Psuedomonas aeruginosa.
Lee JH; Park AK; Chi YM; Moon JH; Lee KS
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Feb; 67(Pt 2):214-6. PubMed ID: 21301088
[TBL] [Abstract][Full Text] [Related]
44. Correlations between FAS elongation cycle genes expression and fatty acid production for improvement of long-chain fatty acids in Escherichia coli.
Lee S; Jung Y; Lee S; Lee J
Appl Biochem Biotechnol; 2013 Mar; 169(5):1606-19. PubMed ID: 23322253
[TBL] [Abstract][Full Text] [Related]
45. The Francisella tularensis FabI enoyl-acyl carrier protein reductase gene is essential to bacterial viability and is expressed during infection.
Kingry LC; Cummings JE; Brookman KW; Bommineni GR; Tonge PJ; Slayden RA
J Bacteriol; 2013 Jan; 195(2):351-8. PubMed ID: 23144254
[TBL] [Abstract][Full Text] [Related]
46. Analysis of Enoyl-Acyl Carrier Protein Reductase Structure and Interactions Yields an Efficient Virtual Screening Approach and Suggests a Potential Allosteric Site.
Ghattas MA; Mansour RA; Atatreh N; Bryce RA
Chem Biol Drug Des; 2016 Jan; 87(1):131-42. PubMed ID: 26259619
[TBL] [Abstract][Full Text] [Related]
47. The kalimantacin/batumin biosynthesis operon encodes a self-resistance isoform of the FabI bacterial target.
Mattheus W; Masschelein J; Gao LJ; Herdewijn P; Landuyt B; Volckaert G; Lavigne R
Chem Biol; 2010 Oct; 17(10):1067-71. PubMed ID: 21035728
[TBL] [Abstract][Full Text] [Related]
48. Mechanism and inhibition of the FabI enoyl-ACP reductase from Burkholderia pseudomallei.
Liu N; Cummings JE; England K; Slayden RA; Tonge PJ
J Antimicrob Chemother; 2011 Mar; 66(3):564-73. PubMed ID: 21393229
[TBL] [Abstract][Full Text] [Related]
49. The Lactococcus lactis FabF fatty acid synthetic enzyme can functionally replace both the FabB and FabF proteins of Escherichia coli and the FabH protein of Lactococcus lactis.
Morgan-Kiss RM; Cronan JE
Arch Microbiol; 2008 Oct; 190(4):427-37. PubMed ID: 18523755
[TBL] [Abstract][Full Text] [Related]
50. Signature gene expression profile of triclosan-resistant Escherichia coli.
Yu BJ; Kim JA; Pan JG
J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062
[TBL] [Abstract][Full Text] [Related]
51. cDNA cloning and expression of Brassica napus enoyl-acyl carrier protein reductase in Escherichia coli.
Kater MM; Koningstein GM; Nijkamp HJ; Stuitje AR
Plant Mol Biol; 1991 Oct; 17(4):895-909. PubMed ID: 1912503
[TBL] [Abstract][Full Text] [Related]
52. Enhanced free fatty acid production by codon-optimized Lactococcus lactis acyl-ACP thioesterase gene expression in Escherichia coli using crude glycerol.
Lee S; Park S; Park C; Pack SP; Lee J
Enzyme Microb Technol; 2014 Dec; 67():8-16. PubMed ID: 25442943
[TBL] [Abstract][Full Text] [Related]
53. AG205, a novel agent directed against FabK of Streptococcus pneumoniae.
Takahata S; Iida M; Osaki Y; Saito J; Kitagawa H; Ozawa T; Yoshida T; Hoshiko S
Antimicrob Agents Chemother; 2006 Aug; 50(8):2869-71. PubMed ID: 16870790
[TBL] [Abstract][Full Text] [Related]
54. Functional expression of Francisella tularensis FabH and FabI, potential antibacterial targets.
Wen L; Chmielowski JN; Bohn KC; Huang JK; Timsina YN; Kodali P; Pathak AK
Protein Expr Purif; 2009 May; 65(1):83-91. PubMed ID: 19095065
[TBL] [Abstract][Full Text] [Related]
55. Enoyl acyl carrier protein reductase (FabI) catalyzed asymmetric reduction of the C=C double bond of α,β-unsaturated ketones: preparation of (R)-2-alkyl-cyclopentanones.
Liu J; Wu J; Li Z
Chem Commun (Camb); 2014 Sep; 50(68):9729-32. PubMed ID: 25019575
[TBL] [Abstract][Full Text] [Related]
56. The food-grade antimicrobial xanthorrhizol targets the enoyl-ACP reductase (FabI) in Escherichia coli.
Yogiara ; Mordukhova EA; Kim D; Kim WG; Hwang JK; Pan JG
Bioorg Med Chem Lett; 2020 Dec; 30(24):127651. PubMed ID: 33130290
[TBL] [Abstract][Full Text] [Related]
57. A triclosan-resistance protein from the soil metagenome is a novel enoyl-acyl carrier protein reductase: Structure-guided functional analysis.
Kim SH; Khan R; Choi K; Lee SW; Rhee S
FEBS J; 2020 Nov; 287(21):4710-4728. PubMed ID: 32112503
[TBL] [Abstract][Full Text] [Related]
58. Activation of Exogenous Fatty Acids to Acyl-Acyl Carrier Protein Cannot Bypass FabI Inhibition in Neisseria.
Yao J; Bruhn DF; Frank MW; Lee RE; Rock CO
J Biol Chem; 2016 Jan; 291(1):171-81. PubMed ID: 26567338
[TBL] [Abstract][Full Text] [Related]
59. The Two Acyl Carrier Proteins of Enterococcus faecalis Have Nonredundant Functions.
Dong H; Cronan JE
J Bacteriol; 2022 Sep; 204(9):e0020222. PubMed ID: 35920666
[TBL] [Abstract][Full Text] [Related]
60. Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression.
Grandgirard D; Furi L; Ciusa ML; Baldassarri L; Knight DR; Morrissey I; Largiadèr CR; Leib SL; Oggioni MR
BMC Genomics; 2015 Apr; 16(1):345. PubMed ID: 25924916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
